期刊文献+

miRNA-196a-5p调控Smad4表达对胃癌干细胞特性的影响 被引量:1

Regulation of Smad4 by miRNA-196a-5p influences gastric cancer stem cell characteristics
下载PDF
导出
摘要 背景:miRNA-196a是新近发现的与乳腺癌、宫颈癌等多种肿瘤相关的microRNAs生物靶分子。研究证实,miRNA-196a-5p在胃癌细胞株和胃癌组织中均表达增加,然而,关于miRNA-196a-5p在胃癌干细胞中的功能和机制研究甚少。目的:分析miRNA-196a-5p在胃癌干细胞侵袭中的作用及机制。方法:流式细胞术分选胃癌BGC-823细胞株中的CD44^+细胞(即胃癌干细胞),qRT-PCR检测miRNA-196a-5p表达,Transwell实验检测细胞侵袭能力;参照Lipofectamine 2000转染试剂说明书的操作步骤,将miRNA-196a-5p inhibitor(即miRNA-196a-5p INH)转染至细胞中;双荧光素酶报告基因实验验证miRNA-196a-5p对Smad4基因的调控作用;Western blotting实验检测上皮-间质转化相关蛋白(E-cadherin、N-cadherin和Vimentin)和Smad4蛋白表达。结果与结论:(1)miRNA-196a-5p在胃癌干细胞中表达增加(P<0.05);(2)抑制miRNA-196a-5p表达后,能够降低胃癌干细胞的侵袭能力(P<0.05),增加E-cadherin蛋白表达(P<0.05),降低N-cadherin和Vimentin蛋白表达(P均<0.05),增加Smad4蛋白表达(P<0.05);(3)结果表明,miRNA-196a-5p通过调控Smad4表达在胃癌干细胞上皮-间质转化和侵袭过程中发挥重要作用,miRNA-196a-5p具有作为胃癌治疗靶标的潜能。 BACKGROUND: miRNA-196a is a recently discovered microRNAs biotarget molecule associated with various tumors such as breast cancer and cervical cancer. Studies have confirmed that miRNA-196a-5p is upregulated in both gastric cancer cell line and gastric cancer tissues. However, little is known about the function and mechanism of miRNA-196a-5p in gastric cancer stem cells.OBJECTIVE: To analyze the function of miRNA-196a-5p in the invasion of gastric cancer stem cells and to investigate the possible mechanism.METHODS: CD44+ gastric cancer stem cells were sorted from the gastric cancer BGC-823 cell line using flow cytometry. The expression of miRNA-196a-5p was detected by quantitative real-time PCR (qRT-PCR) and the cell invasion was determined by Transwell assay. With reference to the specification of Lipofectamine 2000m kit, miRNA-196a-5p inhibitor (miRNA-196a-5p INH) was transferred into the sorted cells. Regulation of Smad4 gene by the miRNA-196a-5p was validated by dual-luciferase reporter gene assay. Expression of epithelial-mesenchymal transition-associated proteins (E-cadherin, N-cadherin and Vimentin) and Smad4 protein was evaluated by western blot assay.RESULTS AND CONCLUSION: The miRNA-196a-5p was up-regulated in the gastric cancer stem cells (P 〈 0.05). Inhibiting the miRNA-196a-5p expression could reduce the invasion ability of gastric cancer stem cells (P 〈 0.05), increase the E-cadherin protein expression (P 〈 0.05), decrease the N-cadherin and Vimentin protein expression (P 〈 0.05), and enhance the Smad4 protein expression (P 〈 0.05). Therefore, miR-196a-5p has a key role in epithelial-mesenchymal transition and invasion by targeting Smad4 in the gastric cancer stem cells. miR-196a-5p may serve as a potential target for gastric cancer therapy.
作者 郭睿 戴建峰 罗玉明 赵海明 唐鹏 Guo Rui;Dai Jian-feng;Luo Yu-ming;Zhao Hai-ming;Tang Peng(Department of Gastroenterology,the East Branch of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu 610000,Sichuan Province,China;College of Forestry and Health,Sichuan Radio and TV University,Chengdu 610000,Sichuan Province,China)
出处 《中国组织工程研究》 CAS 北大核心 2018年第21期3310-3315,共6页 Chinese Journal of Tissue Engineering Research
基金 2017年四川省卫生和计划生育委员会科研课题 普及应用项目(17PJ041)~~
关键词 miRNA-196a-5p 胃癌干细胞 上皮-间质转化 侵袭 SMAD4 胃肿瘤 肿瘤侵润 肿瘤干细胞 微RNAs Smad4蛋白质 组织工程 Stomach Neoplasms Neoplasm Invasiveness Neoplastic Stem Cells MicroRNAs Smad4 Protein Tissue Engineering
  • 相关文献

参考文献2

二级参考文献37

  • 1李晓波,刘文忠,戈之铮,萧树东.报警症状在胃肠道疾病诊断中的作用[J].胃肠病学,2005,10(4):198-202. 被引量:14
  • 2侯培锋,张祥福,郑知文.早期胃癌临床病理特点与外科治疗的远期疗效[J].中华胃肠外科杂志,2007,10(1):53-56. 被引量:19
  • 3赫捷,赵平,陈万青.中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:26.
  • 4FERLAY J, SHIN H,BRAY F,et al. GLOBOCAN2008,cancer incidence and mortality worldwide : IARCCancerBase No. 10 [ Z ]. Lyon : International Agencyfor Research on Cancer 2,2010: 29.
  • 5ISOBEY,NASHIMOTO A, AKAZAWA K,et al.Gastric cancer treatment in Japan ; 2008 annual reportof the JGCA nationwide registry [ J ]. GastricCancer, 2011,14(4):301-316.
  • 6HAMILTOM S R, AAHONEN L A. Pathology andgenetics of tumours of digestion system[ M]. Lyon, 2000.
  • 7ESLICK G D, LIM L L,BYLES J E, et al.Association of Helicobacter pylori infection withgastric carcinoma : a meta-analysis [ J ]. Am JGastroenterol, 1999,94(9) :2373-2379.
  • 8UEMURA N, OKAMOTO S, YAMAMOTO S,et al.Helicobacter pylori infection and the development ofgastric cancer[ J]. N Engl J Med, 2001,345 : 784-789.
  • 9MALFERTHEINER P,MEGRAUD F,O’MORAIN CA, et al_ Management of Helicobacter pyloriinfection-The Maastricht IV/ Florence ConsensusReport[J]. Gut, 2012,61: 646-664.
  • 10YOON S B, PARK J M, LIM C H, et al. Effect ofHelicobacter pylori eradication on metachronousgastric cancer after endoscopic resection of gastrictumors: a meta-analysis [J]. Helicobacter,2014,19(4) :243-248.

共引文献224

同被引文献19

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部